Moderating Growth Could Be A Tough Challenge For Cooper Shares (NASDAQ:COO)
Cooper Companies (COO) faces challenges with moderating revenue growth and margin leverage despite strong execution in segments like contact lenses and myopia management. The company is undertaking a strategic review, exploring options such as divestitures to enhance shareholder value. Although the myopia management unit shows promise, broader Vision and Surgical segments encounter pricing and competitive pressures, leading to the stock being only modestly undervalued with limited catalysts for significant re-rating.
The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Recommendation of "Moderate Buy" from Analysts
The Cooper Companies, Inc. (NASDAQ:COO) has received an average "Moderate Buy" rating from analysts, with a consensus 12-month price target of $90.77. The company recently beat Q4 earnings estimates and provided optimistic FY2026 guidance, while insiders have been actively purchasing shares. Several brokerage firms have adjusted their price targets and ratings on COO shares following these developments.
A Look At Cooper Companies (COO) Valuation After Its Term Loan Amendment And Extended Debt Maturities
Cooper Companies (COO) recently amended its 2021 term loan, extending the maturity of $950 million of debt to 2031, which positions the company for improved cash generation and potential debt reduction/share repurchases. While a fair value analysis suggests the stock is undervalued at around $83 compared to an estimated $91, a P/E ratio comparison indicates it trades at a premium to its industry and peers. Investors are encouraged to consider both cash flow projections and P/E ratios, along with market risks, when evaluating COO's future prospects.
BD Merges Biosciences & Diagnostics Business With Waters
Becton, Dickinson and Company (BD) completed the spin-off of its Biosciences & Diagnostic business, merging it with Waters Corporation, a move that aligns with BD's 2025 strategy to become a more focused MedTech organization. BD shareholders received Waters common stock, and BD gained $4 billion in proceeds, which it plans to use for share repurchases and debt reduction. The company aims to capitalize on trends like connected and AI-enabled medical technologies, strengthening its strategic focus and growth prospects.
The Cooper Companies (COO) Moved Higher as Multiple Tailwinds Align
The Cooper Companies (COO) was highlighted as a top contributor in Sustainable Growth Advisers' (SGA) Q4 2025 investor letter. The company demonstrated strong operating results by alleviating supply constraints, securing new contracts, and driving innovation in its medical device segments. Shareholder-friendly developments, such as revised management compensation incentives and strategic review of its women's health business, also contributed to positive sentiment, leading SGA to maintain an average weight in COO after trimming some of its position.
CooperVision Launches MiSight® 1 day in Japan; Becomes First Myopia Control Contact Lens in Leading Vision Care Market
CooperVision has launched its MiSight® 1 day myopia control contact lens in Japan, making it the first soft contact lens authorized for myopia control in the country. This introduction is significant as Japan is a major vision care market with a high percentage of myopic elementary school children. The lens aims to help slow the progression of myopia in children and is part of CooperVision's broader effort to combat the global rise in nearsightedness.
CooperVision Launches MiSight® 1 day in Japan; Becomes First Myopia Control Contact Lens in Leading Vision Care Market
CooperVision has launched its MiSight® 1 day contact lens in Japan, making it the first soft contact lens authorized by the Japanese Ministry of Health, Labor and Welfare to correct and slow childhood myopia progression. This expansion into Japan, a significant global contact lens market with a high rate of childhood myopia, highlights CooperVision's commitment to providing evidence-based myopia management solutions worldwide. The lens has demonstrated an average 59% reduction in myopia progression over three years and is approved in over 40 countries.
BI Asset Management Fondsmaeglerselskab A S Sells 197,423 Shares of The Cooper Companies, Inc. $COO
BI Asset Management Fondsmaeglerselskab A S has significantly reduced its stake in The Cooper Companies, Inc. (NASDAQ:COO), selling 197,423 shares and leaving them with 9,550 shares. This comes as Cooper Companies reported strong quarterly earnings, beating analyst expectations, and provided optimistic FY2026 guidance. While some institutional investors increased their holdings, overall sentiment remains a "Moderate Buy" among analysts, with a consensus target price of $90.77.
Hantz Financial Services Inc. Cuts Stock Position in The Cooper Companies, Inc. $COO
Hantz Financial Services Inc. significantly reduced its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 94.1% in Q3, selling 82,901 shares and retaining 5,202 shares valued at approximately $357,000. Despite this reduction, Wall Street analysts generally hold a "Moderate Buy" rating for COO with an average price target of $90.77. Recent insider transactions show executives acquiring shares, with CEO Albert G. White III and a director purchasing a total of 12,000 shares, indicating confidence from within the company.
Diamond Hill Capital Management Inc. Makes New Investment in The Cooper Companies, Inc. $COO
Diamond Hill Capital Management Inc. has initiated a significant new investment in The Cooper Companies, acquiring 567,243 shares valued at approximately $38.89 million. This investment comes amidst improving analyst sentiment, with a consensus "Moderate Buy" rating and a price target of $90.77, following recent positive earnings. Insider buying, including by the CEO, further signals confidence in the medical device company.
Cooper Companies Stock: Analyst Estimates & Ratings
This article provides an overview of analyst estimates and ratings for Cooper Companies (NYSE: COO) stock. It covers the current average rating, price targets, and potential upside based on recent analyst projections, indicating a generally positive outlook for the company.
Federated Hermes Inc. Cuts Holdings in Electronic Arts Inc. $EA
Federated Hermes Inc. significantly reduced its stake in Electronic Arts (NASDAQ:EA) by 96.1% in Q3, selling over 101,000 shares. Despite EA beating Q3 revenue estimates driven by Battlefield 6 and announcing a dividend, the company faced a profit decline, elevated merger-related risk, and a premium valuation, leading to an overall "Hold" consensus among analysts. Insider selling activity also totaled nearly $25 million in the past 90 days.
Bessemer Group Inc. Sells 487,158 Shares of The Cooper Companies, Inc. $COO
Bessemer Group Inc. significantly reduced its stake in The Cooper Companies by 26.6% in Q3, selling 487,158 shares but still holding 1,341,718 shares valued at $91.99 million. Concurrently, Ruffer LLP substantially increased its holding by 444.2%, acquiring 1,100,188 shares to own a total of 1,347,850 shares. Cooper Companies exceeded Q3 estimates with $1.15 EPS and $1.07 billion in revenue, and analysts currently rate the stock as a "Moderate Buy" with a target price of $90.77.
nLIGHT Equity Raise Fuels Defense Laser Expansion And Execution Focus
nLIGHT (NasdaqGS:LASR) has completed a $175 million equity offering to expand its high-energy laser manufacturing for defense applications, signaling a strategic focus on this growing sector. The capital raise follows strong revenue trends and new defense contracts, positioning the company for increased production and contract conversion. Investors are weighing the potential benefits of this expansion against near-term share dilution and the inherent risks of heavy reliance on government defense programs.
Fund Update: 2,720,594 COOPERS (THE) (COO) shares added to DIAMOND HILL CAPITAL MANAGEMENT INC portfolio
DIAMOND HILL CAPITAL MANAGEMENT INC has significantly increased its stake in COOPERS (THE) (COO) by adding 2,720,594 shares to its portfolio, as per a recent SEC 13F filing for the Q4 2025 period. The article also details recent hedge fund activity, insider trading, congressional stock trading, and analyst ratings and price targets for COO, indicating general investor interest and positive sentiment from most analysts.
CooperCompanies to review Q1 2026 results on March 5 call
CooperCompanies (Nasdaq: COO) announced it will report its first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. Following the release, the company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. A live audio webcast and replay will be available on the company investor website.
CooperCompanies Announces Release Date for First Quarter 2026
CooperCompanies announced it will report its first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. The company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. A webcast and replay of the call will be available on their investor relations website.
CooperCompanies Announces Release Date for First Quarter 2026
CooperCompanies (Nasdaq: COO) announced it will report its first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. A conference call will follow at 5:00 PM ET to discuss the results and corporate developments. A webcast of the call will also be available on the company's investor relations website.
Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates
Align Technology (ALGN) has exceeded Q4 earnings and revenue estimates, reporting $3.29 EPS against an expected $2.99, and revenues of $1.05 billion, surpassing the consensus by 1.33%. The company has consistently beaten EPS and revenue estimates over the last four quarters. Despite underperforming the S&P 500 year-to-date, its favorable earnings outlook has earned it a Zacks Rank #2 (Buy).
Tires Market to Surpass USD 191.24 Billion by 2032, Driven by Vehicle Production, EV Demand, and Global Tire Industry Growth: Maximize Market Research
The global tires market is projected to grow from USD 143.38 billion in 2025 to USD 191.24 billion by 2032, driven by increased vehicle production, rising demand for electric vehicles, and advancements in tire technologies. Radial tires and passenger car segments currently dominate the market, while Asia-Pacific remains the largest regional market due to booming automotive sales and manufacturing capabilities. Innovations in smart, eco-friendly, and high-performance tires are expected to further fuel market expansion.
Manning & Napier Group, LLC Reduces Stake in UnitedHealth Group Inc by 65.05%
Manning & Napier Group, LLC significantly reduced its stake in UnitedHealth Group Inc (NYSE:UNH) by 65.05% in the fourth quarter of 2025. This reduction resulted in a -2.48% impact on their portfolio. The firm also made notable additions to its portfolio, including United Parcel Service Inc (NYSE:UPS) and The Cooper Companies Inc (NASDAQ:COO), and increased positions in Elevance Health Inc (NYSE:ELV) and ASML Holding NV (NASDAQ:ASML).
Is Cooper’s Debt Extension And Fresh Institutional Interest Reframing The Investment Case For COO?
The Cooper Companies recently extended US$950 million of its term loans to 2031 and increased its incremental borrowing cap, offering greater financial flexibility. This balance sheet restructuring, combined with a new institutional investment by Diamond Hill Capital, is reshaping the investment narrative for COO despite recent share price weakness. While operational catalysts like stabilizing earnings and improving returns on equity remain key, the extended debt maturity introduces a financial risk factor for investors to consider.
Cooper Co Amends Loan Facilities to Enhance Flexibility
Cooper Co (COO) recently amended its 2021 Term Loan Agreement and 2024 Revolving Credit Agreement to extend term loan maturities, increase borrowing limits, and adjust pricing options. These changes aim to enhance the company's financial flexibility, streamline its capital structure, and provide long-term funding stability. TipRanks' AI Analyst, Spark, rates COO as "Outperform," citing strong financial health and strategic growth, despite high valuation and market challenges in China.
Cooper Companies Updates Multiple Financing Agreements With PNC Bank
Cooper Companies has updated two significant financing agreements with PNC Bank to enhance flexibility and align pricing terms. The firm amended its 2021 Term Loan Agreement, extending $950 million of loans to February 3, 2031, removing credit spread adjustments, and increasing incremental capacity. Additionally, it amended its 2024 Revolving Credit Agreement to conform provisions and ensure consistent pricing, all aimed at bolstering liquidity and long-term capital planning.
Will the Cooper Companies (COO) beat estimates again in its next earnings report?
This article discusses the Cooper Companies (COO) and whether it will beat its upcoming earnings estimates. It highlights COO's strong earnings surprise history and its Zacks Rank, suggesting a positive outlook for the company's next report. Investors are encouraged to consider these factors when evaluating COO's stock.
Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report?
The Cooper Companies (COO) is expected to continue its earnings-beat streak in its upcoming report, as indicated by a positive Zacks Earnings ESP of +0.24% and a Zacks Rank #2 (Buy). The company has consistently topped earnings estimates in its last two reports, with an average surprise of 3.20%. These factors suggest a high probability of another positive surprise for the surgical and contact lens products maker.
Reasons to Add Cooper Companies Stock to Your Portfolio Now
The Cooper Companies (COO) is positioned for growth due to strong performance in its CooperVision segment, particularly with its MyDay premium lens portfolio, and advancements in CooperSurgical's women's health and fertility offerings. While the company anticipates meaningful margin and free cash flow expansion, it faces challenges from gross margin pressures related to product mix and tariffs, as well as weakness in the Asia-Pacific market and uncertainty in the fertility sector. Despite these headwinds, the company's aggressive shareholder returns, disciplined capital allocation strategy, and positive long-term growth estimates make it an attractive investment.
Cooper Group Brokers Sale of Chipotle-Occupied Restaurant Property in Piqua, Ohio
The Cooper Commercial Investment Group has brokered the sale of a newly constructed restaurant property in Piqua, Ohio, occupied by Chipotle Mexican Grill. The property sold to an all-cash 1031 exchange buyer from California at a 5.5 percent cap rate. The 15-year lease includes 10 percent rental increases in years six and 11, and the property features a Chipotlane drive-thru and patio seating.
Cooper Companies (NASDAQ:COO) Price Target Cut to $99.00 by Analysts at Needham & Company LLC
Needham & Company LLC has lowered its price target for Cooper Companies (NASDAQ:COO) from $100 to $99, while maintaining a "buy" rating, indicating a potential upside of 22.75%. The report notes that Cooper Companies recently exceeded quarterly earnings and revenue estimates and provided positive FY2026 guidance. Insider activity shows recent stock purchases by the CEO and a director.
Cooper Companies stock price target lowered to $99 by Needham
Needham has lowered its price target for Cooper Companies (NASDAQ:COO) to $99.00 from $100.00, while maintaining a Buy rating. This adjustment comes due to potential competitive pressure from Sebela’s upcoming Miudella launch, which could impact Cooper’s Paragard IUD sales and put up to 90 basis points of EPS pressure in fiscal year 2027. Despite these concerns, Cooper Companies has shown strong financial health and growth, with other firms like Mizuho and William Blair also maintaining positive ratings and raising price targets.
Deep Dive Into Cooper Companies Stock: Analyst Perspectives (13 Ratings)
Thirteen analysts have recently evaluated Cooper Companies (NASDAQ: COO), offering a range of perspectives from bullish to bearish, with an average price target of $89.08, marking a 10.18% increase from the previous average. The article details individual analyst actions, including rating and price target adjustments. It also provides a financial overview of Cooper Companies, highlighting its market capitalization, revenue growth, net margin, return on assets, and debt management, while noting its return on equity is below industry standards.
Diamond Hill Large Cap Fund Purchased Cooper Companies (COO) Betting on the Resilient Contact Lens Industry
Diamond Hill Large Cap Fund recently initiated a position in Cooper Companies (COO), a medical device manufacturer specializing in contact lenses and women's health. The investment firm believes that while the company has faced some recent revenue deceleration and executional challenges, the long-term growth prospects for the contact lens industry remain healthy, and the women's health segment operates in a market with secular tailwinds. This move comes despite a recent dip in Cooper Companies' stock value, with the fund maintaining a cautious stance on AI-driven market enthusiasm and preferring fundamentally stable businesses.
Diamond Hill Large Cap Fund Purchased Cooper Companies (COO) Betting on the Resilient Contact Lens Industry
Diamond Hill Large Cap Fund initiated a new position in Cooper Companies, Inc. (COO) during the fourth quarter of 2025, despite a recent decline in its stock value. The fund believes that while the company faces short-term challenges, its leadership in the contact lens industry and the long-term secular tailwinds in its women's health and fertility segment present attractive investment opportunities. This move reflects Diamond Hill's preference for fundamentally stable, high-quality businesses over AI-driven market enthusiasm.
A Look At Cooper Companies (COO) Valuation As Business Review And Activist Pressure Refocus Attention
Cooper Companies (COO) is gaining investor attention due to renewed analyst coverage, activist investor pressure, and a potential business separation of its CooperVision and CooperSurgical divisions. The company's valuation is currently debated, with an intrinsic value estimate suggesting it is 9% undervalued and an analyst price target indicating a 13% discount, primarily driven by expectations of increased free cash flow from winding down capital expenditure. However, its high P/E ratio compared to the industry suggests potential valuation risk.
Cooper Companies (NASDAQ:COO) Upgraded at William Blair
William Blair has upgraded Cooper Companies (NASDAQ:COO) to a "strong-buy" rating. This upgrade follows Cooper's strong financial performance, beating Q3 earnings and revenue estimates and providing optimistic FY2026 guidance. Insider activity also showed significant buying in December, indicating confidence in the company's prospects.
Nan Fung Trinity HK Ltd. Invests $11.72 Million in Danaher Corporation $DHR
Nan Fung Trinity HK Ltd. recently acquired a new stake of 59,100 shares in Danaher Corporation during the third quarter, valued at approximately $11.72 million. Danaher reported strong Q4 EPS results and provided an optimistic FY2026 EPS guidance, leading to several price target upgrades from analysts despite some market caution regarding its elevated valuation and "in-line" revenue outlook. The article also details insider selling activity and institutional ownership, highlighting Danaher's recent performance and analyst sentiment.
Envestnet Portfolio Solutions Inc. Cuts Stake in The Cooper Companies, Inc. $COO
Envestnet Portfolio Solutions Inc. significantly reduced its stake in The Cooper Companies (NASDAQ:COO) by 61.9% in Q3, selling over 16,000 shares. Despite this, company insiders, including CEO Albert G. White III, have been buying shares, with over 16,000 shares acquired in the last 90 days. Cooper Companies reported a slight beat on Q3 earnings and revenue and provided FY26 EPS guidance, while analysts currently hold a "Hold" consensus rating with an average target price of $90.85.
Here's Why West Pharmaceutical (WST) Is a Great 'Buy the Bottom' Stock Now
West Pharmaceutical (WST) has recently experienced a bearish trend, but a hammer chart pattern suggests a potential trend reversal. This technical indicator, combined with rising earnings estimates and a Zacks Rank #2 (Buy), points to an improving outlook for the medical device company. Investors are advised to consider WST as a potential "buy the bottom" opportunity.
William Blair resumes Cooper Companies stock coverage with Outperform rating
William Blair has reinstated its coverage of Cooper Companies (NASDAQ:COO) with an Outperform rating, citing the company's expected net income growth and recent strategic initiatives to enhance shareholder value. Despite a period of underperformance and activist investor pressure, Cooper Companies is trading at a discount to peers with similar growth potential. Analysts suggest the stock is undervalued, with recent strong financial results and strategic appointments further supporting a positive outlook.
The Cooper Companies, Inc. $COO Shares Bought by Ruffer LLP
Ruffer LLP significantly increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 444.2% in the third quarter, now owning 1,347,850 shares valued at approximately $92.4 million. Insider activity also showed purchases, with CEO Albert G. White III and Director Maria Rivas acquiring shares. The company surpassed quarterly earnings and revenue estimates, providing FY2026 EPS guidance, and holds a consensus analyst rating of "Hold" with a $90.85 price target.
1 Healthcare Stock to Own for Decades and 2 We Question
This article identifies Humana (HUM) as a healthcare stock with long-term potential, citing its strong revenue growth, dominant market position primarily in Medicare Advantage, and effective capital management. Conversely, it advises caution on CooperCompanies (COO) and Phibro Animal Health (PAHC) due to concerns like unexciting sales trends, declining free cash flow, and disadvantages against larger competitors, respectively. Investors are encouraged to consider these factors when building a robust portfolio in the healthcare sector.
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Merit Medical Systems, Inc. (MMSI) is recommended as a strong buy due to its robust product portfolio, including the WRAPSODY CIE and an expanding high-margin product line, and strong free cash flow generation. Despite potential headwinds like reimbursement uncertainty and macroeconomic volatility, the company shows a positive estimate revision trend for 2026, with an impressive average earnings surprise of 14.1% over the past four quarters.
Why Merit Medical (MMSI) is Poised to Beat Earnings Estimates Again
Merit Medical (MMSI) is anticipated to beat its upcoming earnings estimates, continuing a strong trend from previous reports. The company has a history of exceeding earnings expectations, with an average surprise of 14.82% over the last two quarters. This positive outlook is further supported by the stock's positive Zacks Earnings ESP and a Zacks Rank #2 (Buy), indicating a high probability of another earnings beat.
How Investors Are Reacting To Cooper Companies (COO) Upbeat Fiscal 2026 EPS Guidance And Earnings Momentum
Cooper Companies (COO) recently provided upbeat fiscal 2026 EPS guidance of US$4.45 to US$4.60, along with a track record of meeting or exceeding earnings estimates. While this reinforces confidence in its earnings trajectory, the muted market reaction suggests this was largely anticipated. The company's investment narrative centers on converting revenue growth into profitability, with risks including low returns on equity and slower projected revenue growth compared to the broader US market, despite a pending strategic review and active buyback program.
Gulfport Energy Corporation $GPOR Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in Gulfport Energy Corporation (NYSE:GPOR) by 19.9% in the third quarter, while other institutional investors like Global Alpha Capital Management and Pacer Advisors increased or established positions. The article highlights significant insider selling, with Silver Point Capital and COO Matthew Rucker offloading shares worth millions. Despite missing EPS expectations, Gulfport Energy received a "Moderate Buy" consensus target price from analysts.
What you need to know ahead of the Cooper Companies' earnings release
This article provides key information for investors to consider before The Cooper Companies (COO) releases its Q1 2024 earnings report. It highlights analyst expectations for earnings per share and revenue, details the company's past earnings performance, and outlines factors that could influence the upcoming results.
What to Be Aware of Before The Cooper Companies Announce Their Earnings
The Cooper Companies (COO), a medical device manufacturer, is expected to announce its Q1 fiscal 2026 earnings soon, with analysts forecasting $1.03 per share, a 12% increase year-over-year. The company has consistently met or exceeded Wall Street expectations. While COO's stock has lagged behind the S&P 500 and healthcare ETFs over the past year, strong Q4 2025 results and optimistic fiscal 2026 guidance have contributed to cautious optimism among analysts, with an average price target suggesting an 8.8% potential upside.
What You Need to Know Ahead of The Cooper Companies' Earnings Release
The Cooper Companies (COO), a medical device company, is set to announce its fiscal Q1 2026 earnings soon. Analysts anticipate a 12% increase in profit to $1.03 per share for the quarter and project continued EPS growth for fiscal years 2026 and 2027. Despite a 13% decline in stock performance over the past 52 weeks, Wall Street analysts have a "Moderate Buy" rating with an average price target indicating an 8.8% potential upside.
What You Need to Know Ahead of The Cooper Companies' Earnings Release
The Cooper Companies, Inc. (COO) is set to announce its fiscal Q1 2026 earnings, with analysts expecting a 12% increase in profit per share to $1.03. The company has consistently exceeded Wall Street's earnings estimates and projects continued growth through fiscal 2027. Despite underperforming the broader market over the past year, analysts maintain a "Moderate Buy" rating with an 8.8% potential upside.
What You Need to Know Ahead of The Cooper Companies' Earnings Release
The Cooper Companies (COO) is set to announce its Q1 2026 earnings, with analysts expecting a 12% increase in profit to $1.03 per share. The company has consistently surpassed Wall Street estimates and provided upbeat fiscal 2026 guidance. Despite underperforming market indices over the past year, analysts assign a "Moderate Buy" rating with an 8.8% potential upside.
